Familial hyperchylomicronaemia [23]

Lancet

Volumn 348, Issue 9040, 1996, Pages 1524-1525

  Wierzbicki, A S ^a   Reynolds, T M ^a   Gasbarrini, G ^a   Mingrone, G ^a   Greco, A V ^a   Castagneto, M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FIBRIC ACID DERIVATIVE; GLUCOSE; LIPOPROTEIN LIPASE; NICOTINIC ACID; TRIACYLGLYCEROL; VITAMIN; ANTILIPEMIC AGENT;

ATHEROSCLEROSIS; BILIOPANCREATIC BYPASS; DIET SUPPLEMENTATION; DIET THERAPY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; INSULIN RESISTANCE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREATITIS; PRIORITY JOURNAL; SURGICAL MORTALITY; TRIACYLGLYCEROL BLOOD LEVEL; XANTHOMA; NOTE;

ANTILIPEMIC AGENTS; HUMANS; HYPERLIPOPROTEINEMIA TYPE I;

EID: 0030607589     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)65951-x     Document Type: Letter

References (5)

1. RB Tattershall Mild familial diabetes with dominant inheritance Q J Med 70 1974 339 357
2. A Chait JD Brunzell Chylomicronaemia syndrome Adv Intern Med 37 1991 249 273
3. DA Wilson A Hata LK Kwong Mutations in exon 3 of the lipoprotein lipase gene segregation in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes J Clin Invest 92 1993 203 211
4. WO Richter BG Jacob MM Ritter P Schwandt Treatment of primary chylomicronaemia due to familial hypertriglyceridemia by ω-3 fatty acids Metabolism 41 1992 1100 1105
5. P Benlian JL De Gennes L Foubert H Zhang E Gagne M Hayden Premature atherosclerosis in patients with familial chylomicronaemia caused by mutations in the lipoprotein lipase gene N Engl J Med 335 1996 848 854